ANAKOINOSIS - Re-Establishing Apoptosis Competence via Communicative Reprogramming: A Novel Anticancer Therapy (Pathophysiology - Preclinic - Clinic)

  • 20k

    Total downloads

  • 82k

    Total views and downloads

Submit your idea

You will be redirected to our submission process.

Submit your manuscript summarySubmit your manuscript

About this Research Topic

Submission closed

Background

The genetic view of tumor transformation and progression led to identifying and targeting molecular cancer hallmarks, allowing selective killing of cancer cells harboring specific oncogene mutations, dramatically increasing therapy tolerability, remission rate and duration. The justified enthusiasm, however, must face the fact that many patients undergo fatal relapses: Cancer cell repopulation and high mutation rate point to intrinsic limitations, implying that a change of paradigm is required to eradicate cancer.

It is often disregarded that the cancer cell phenotype is a recessive trait, and is environmentally determined despite oncogene mutations. When considering such issues, it becomes apparent that correcting the deranged homeostasis of tumor cells and adjacent microenvironment would be a reliable therapeutic option to achieve stable tumor regression.

Communicative reprogramming therapies are a set of biomodulatory therapies aimed at resetting cancer tissue communicative rules (from the Grecian “anakoinosis”, communication) for re-establishing apoptosis competence with regulatory active drug cocktails, such as epigenetically active agents, agonists of transcription factors, metronomic low-dose chemotherapy etc..

For this purpose, it is necessary to merge the comprehensive notions on oncogenes, tumor suppressor genes and epigenetics, with the still incomplete knowledge on homeostatic pathways encompassing tumor cells, adjacent stroma, endothelial cells, immune infiltration and extracellular matrices.

Notable clinical achievements with ‘Communicative Reprogramming’ strategies indicate that this approach complies with the expectations. Otherwise refractory metastatic cancer patients would not successfully respond to anakoinosis inducing therapies despite of quite different histology or disease stages, or mutational patterns: The tools for cancer reconditioning may thus be universal, implying a prospectively more sustainable therapeutic applicability even for economic reasons.

Details for Authors –

A strong motivation for this Research Topic – which will be strictly linked to the Second Conference on “ANAKOINOSIS - Re-establishing apoptosis competence via communicative reprogramming: A novel anticancer therapy” scheduled for April 19-20 2018 in Roma - is the necessity to create a scientific network, where diversified expertise (clinics, cell-developmental- molecular biology, pharmacology, pathology, histology, etc.) converge to explain and support the potential development of biomodulatory anticancer therapies. Separate cancer-related fields may benefit from a focused exchange of information, providing more sensible means of treating cancer clinically.

It is urgent to decipher the very complex mechanisms controlling tissue homeostasis, and this requires a concerted interdisciplinary approach. Gathering studies by scientists with different expertise may be an ideal platform for assessing the cutting edge of current knowledge on the various key issues, and starting developing a network for future development.

We expect that the contributors provide general review papers in their own specific fields, focusing on the connections that link their area of expertise with the backbone of the Research Topic. Original research papers, providing novel information useful to focus the anakoinosis principles, will be also welcome. Given the high interdisciplinary nature of this Research Topic, which is ideally destined to a very broad readership, we will ask contributors to pay particular care to making the introduction section of their studies (either experimental or review), especially clear and comprehensible to non-specialists, in order to facilitate the exchange of knowledge.

This Research Topic might be sub-divided into narrower sub-fields so that the different experts may more easily find their own collocation. Here follows a list of possible themes, considering that this does not exclude additional issues that may be proposed by the contributors and considered pertinent by the Guest Editors:

TUMOR BIOLOGY: AN EVER-CHANGING STATE-OF- THE-ART AND THE NECESSITY OF MERGING QUITE DIFFERENT RESEARCH FIELDS
 Tumor suppressor genes and tumor phenotype
 Epigenetic control of cell and tissue fate are a continuum
 Cell-autonomous and non-autonomous defence mechanisms against oncogene mutation and phenotypic tumor transformation
 Exiting from the cell: the aberrant homeostasis of cancer microenvironment in cancer genesis, progression and spreading
 Injured tissue homeostasis is differently controlled by DNA damage response in healthy and tumor tissues: loss of apoptosis competence in cancer
 Apoptosis, caspases and regeneration in injured normal and cancer tissues: a concern in anticancer therapies
 Microenvironment vs. oncogene mutations as the driving force in tumor genesis and progression: cancer phenotype and oncogene mutations are recessive traits

BIOMODULATORY APPROACHES AND COMMUNICATIVE REPROGRAMMING IN CLINICAL ANTICANCER THERAPIES: ANAKOINOSIS
 Acute myelocytic leukemia: induction of anakoinosis
 Chronic myelocytic leukemia/Langerhans cell histiocytosis: the role of pioglitazone
 How to overcome poor risk molecular-genetic parameters in APL with anakoinosis inducing therapy (ATRA plus ATO)
 Classic targeted therapy combined with anakoinosis inducing therapy
 Metronomic chemotherapy: integrating the treatment concept
 Metformin: how should we therapeutically proceed?
 Transcriptional modulators in tumor therapy
 Epigenetically modifying drugs and anakoinosis inducing therapy
 Epigenetic and differentiation therapy
 Clinical achievements with communicative reprogramming in anticancer therapy
 How to overcome the problem with undruggable targets
 Addressing molecular-genetic tumor heterogeneity in metastatic disease
 Modulatory drug combination: clinical achievements
 Therapeutic modulation of tissue homeostasis in tumor microenvironment
 Hepatocellular carcinoma and anakoinosis inducing therapy
 PPARgamma agonists as universal effectors of cancer homeostasis normalization

ANAKOINOSIS AND CANCER CARE SUSTAINABILITY
 Drug repurposing: Concepts to integrate the idea in clinical strategies
 Ever increasing costs of targeted anticancer therapies: biomodulatory therapies as a sustainable alternative
 Development of pharmacological tools for producing efficacious and economically relevant biomodulatory drug cocktails

ANAKOINOSIS, AN UBIQUITOUS PHENOMENON OF SYSTEMS BIOLOGY
 Communication between metastatic tumor and organ systems: Example cachexia

PRECLINICAL STUDIES AND EXPERIMENTAL MODELS TO EXPLORE EFFICIENT ANAKOINOSIS DRUG
COMBINATIONS
 Modulatory drug combination: translational studies
 Targeting homeostatic systems: tumor suppressor genes and homeostatic pathways
 Developing tools to study anakoinosis principles and improve its therapeutic efficacy (3D cultures,organ-on- chip, zebrafish)
 Natural compounds as anakoinosis drugs: potentials, limits and prospective developments

Keywords: homeostasis of tumor tissue, epigenetics, tumor suppressor genes, undruggable targets, transcriptional modulators

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

     

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

     

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

     

Impact

  • 82kTopic views
  • 59kArticle views
  • 20kArticle downloads
View impact